In her witness statement to the Inquiry, Hazel Blears stated that the rationale for not setting up a compensation scheme for those with Hepatitis C was that there had been no fault on the part of the NHS, action had been taken to screen blood products as soon as the technology became available and there was no precedent for accepting liability without fault.